Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Secaucus, New Jersey
- Most recent report
- 10-Q, filed Jul 23, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1022079
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 41
News 8 of 122
Prospectuses and Registrations 8 of 28
- 424B2 Prospectus supplement for an offering Apr 28, 2026
- FWP Free writing prospectus Apr 27, 2026
- 424B2 Prospectus supplement for an offering Apr 27, 2026
- S-3ASR Automatic shelf registration Jun 20, 2025
- 424B2 Prospectus supplement for an offering Aug 16, 2024
- FWP Free writing prospectus Aug 15, 2024
- 424B2 Prospectus supplement for an offering Aug 15, 2024
- 424B2 Prospectus supplement for an offering Oct 31, 2023
Proxies 8 of 28
- DEFA14A Extra proxy material Apr 6, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 6, 2026
- DEFA14A Extra proxy material Apr 11, 2025
- DEFA14A Extra proxy material Apr 4, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 4, 2025
- PX14A6G Shareholder's own proxy material Apr 11, 2024
- DEFA14A Extra proxy material Apr 5, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 5, 2024
Ownership 8 of 767
- 4 Insider reported a trade Sep 3, 2026
- 144 Notice of a proposed sale of restricted stock Sep 1, 2026
- 4 Insider reported a trade Aug 31, 2026
- 144 Notice of a proposed sale of restricted stock Aug 28, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jul 29, 2026
- 144 Notice of a proposed sale of restricted stock Jul 28, 2026
- 4 Insider reported a trade Jul 27, 2026
Other 8 of 14
- 11-K Employee stock plan report Jun 18, 2026
- 11-K Employee stock plan report Jun 20, 2025
- 11-K Employee stock plan report Jun 21, 2024
- 11-K Employee stock plan report Jun 22, 2023
- 11-K Employee stock plan report Jun 23, 2022
- 11-K Employee stock plan report Jun 28, 2021
- 11-K Employee stock plan report Jun 29, 2020
- 11-K Employee stock plan report Jun 27, 2019
What to read: Jun 2026 10-Q
SECSift found 2 of 10 sections worth reading, with 2 positive, 5 notable, and 0 negative flags.
Part I
Full financial statements and notes with company-specific results and events.Notable- Corewell Health joint venture closed Jan 2026, adding $179M goodwill and $124M intangible assets.
- Issued $500M 5% senior notes due 2036, net proceeds repaid $500M 3.45% notes due June 2026.
- ERISA litigation summary judgment upheld by Third Circuit; company won.
- Legal reserves decreased to $17M at June 30, 2026 from $20M at Dec 31, 2025.
Management's Discussion (Item 2)
Detailed Q2 2026 results, new debt offering, Corewell venture, and buyback activity.
What changed: Jun 2026 vs. Mar 2026
About 25% of DGX's Jun 2026 10-Q is new information. 72 paragraphs were added, 130 changed, and 14 removed. Below are the most important lines SECSift identified.
New
Changed
- Contingent consideration increased from $96M (Dec 2025) to $100M (Jun 2026); in Q1 it was $99M. Part I
- Share repurchases: none in Q1 2026, $100M in H1 2026 ($100M in Q2). Part I
- Added Exhibits 4.1 (Twenty-Fourth Supplemental Indenture) and 4.2 (Form of 5.000% Senior Note due 2036). Item 6
- XBRL schema and linkbase dates updated from 20260331 to 20260630. Item 6
Removed
Everything here comes from Quest Diagnostics Inc's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Aug 19, 2026, from the 10-Q for Jun 2026.